Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

RidgeWorth Silvant Small Cap Growth Stock Fund C Shares (SSCFX)

4.52
Net Asset Value
-0.44%
1 Day
+9.98%
Year-to-Date
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
2.02%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks to provide long-term capital appreciation. The fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in U.S.-traded equity securities of small-capitalization companies. U.S.-traded equity securities may include American Depositary Receipts. The subadvisor considers small-capitalization companies to be companies with market capitalizations similar to those of companies in the Russell 2000  Growth Index.

Performance

1 month+7.11% 3 years+1.36%
3 months+7.62% 5 years+10.07%
1 year+8.48% Since inception+8.44%
Data through --

Peer Comparisonvs. Small growth

 SSCFXCategory
Performance 5-yr return+10.07%+14.42%
Expense ratio2.02%1.33%
Risk 5 year sharpe ratio0.700.84
Net assets$45.4M$852.9M
Average market cap$1.8B$2.9B
Average P/E21.624.6
Portfolio turnover73%73%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyRidgeWorth
Fund manager & tenureMichael Sansoterra / 9 Years
Minimal initial investment$5,000.00
Minimum IRA investment$2,000.00

Holdings

U.S. stock99.28%
Cash0.72%
International stock0.00%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Consumer goods 14.53%
Healthcare 14.32%
Industrial materials 13.64%
Business service 9.70%
Consumer service 7.91%
Top 10 Holdings
Portfolio weighting
PFPT Proofpoint Inc1.97%
QTWO Q2 Holdings Inc1.93%
PAYC Paycom Software Inc1.88%
EGHT 8x8 Inc1.85%
ELLI Ellie Mae Inc1.78%
NXTM NxStage Medical Inc1.74%
BCPC Balchem Corp1.72%
INGN Inogen Inc1.69%
IDTI Integrated Device Technology Inc1.68%
IPHI Inphi Corp1.66%